News World Eli Lilly starts trial of rheumatoid arthritis drug in COVID-19 patients

Eli Lilly starts trial of rheumatoid arthritis drug in COVID-19 patients

 

Eli Lilly and Co on Monday said it was launching a study of its rheumatoid arthritis drug baricitinib in patients hospitalized for COVID-19.

The trial is one of several efforts by the U.S. drugmaker to help combat the coronavirus pandemic, which has killed more than 400,000 people globally, according to a Reuters tally.

The drug is being tested to see if it can reduce deaths from the COVID-19 illness and lessen its severity. Scientists at Lilly believe that baricitinib could help suppress a potentially lethal immune response to COVID-19 called “cytokine storm” and reduce COVID-19’s ability to reproduce in infected cells.

The trial began dosing patients last week and plans to enroll around 400 patients globally. Lilly could potentially obtain U.S. regulatory approval for the drug as soon as August, Patrik Jonsson, the president of Lilly Bio-Medicines, told Reuters in an interview.

Lilly has also been working with the National Institutes of Health to study baricitinib, which is branded Olumiant, in a pairing with Gilead Sciences Inc’s antiviral drug remdesivir. That study began enrolling patients last month.

The U.S. Food and Drug Administration granted Gilead’s remdesivir emergency use authorization (EUA) last month, citing results from a U.S. government study that showed the drug reduced hospitalization stays by 31%, or about four days, compared to a placebo.

Lilly could potentially receive approval to use baricitinib in combination with remdesivir by as early as July, Jonsson said.

Seperately, Lilly could have an drug specifically designed to treat COVID-19 authorized for use as early as September if all goes well with either of two antibody therapies it is testing, its chief scientist told Reuters last week.

(Reuters)

Top Stories

Where to get antigen rapid tests on Monday, 25 January

The Health Ministry announced the following antigen rapid test sites for Monday, 25 January 2021:   LIMASSOL Parking place Lidl supermarket, Limassol 08:30-16:30 Parking place Sklavenitis supermarket, Germasoyia...

130 new cases, three deaths announced on Sunday

The Health Ministry announced the death of three persons due to COVID-19. This raises the death toll from the virus in Cyprus to 186,...

-2 C on Troodos Mountain tonight

Tonight the weather will be mainly fine. Winds will be north-westerly to north-easterly, moderate, force 3 Beaufort. The sea will be slight to rough. The temperature...

Health Ministry to examine use of colchicine for COVID-19 patients

Regarding the use of colchicine to patients with COVID-19, due to relevant announcements made in Greece and Canada, the Advisory Committee of the Health...

Expert says lifting of all measures possible by March, if epidemiological figures allow it

Dr Petros Karayiannis, member of the Scientific Committee on the pandemic and Professor of Microbiology/Molecular Virology at the University of Nicosia Medical School has...

Taste

Squash soup

Ingredients: 1 kg pumpkin, cut into small cubes, approximately 5 cups 2 medium (400g) sweet potatoes, cut into cubes, approximately 2 ½ cups 1 chopped leek, only...

Mezedes

No visit to Cyprus is complete without enjoying the traditional meal of many small dishes known as ‘meze’. This large feast, which has been a...

Prawns with fried cheese, barley shaped pasta

Put the barley shaped pasta into a small pan with salted water, bring to a boil and when tender, drain. Peal the prawns leaving...

Salmon and shrimp sheftalies

Mix all ingredients for tabbouli in a bowl and keep to one side so flavours can combine. Prepare the sheftalies: wash and soak the casing...